BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 26000395)

  • 1. The inhibitory effects of a monoclonal antibody targeting neuropilin-1 on adhesion of glioma cells to fibronectin.
    Chen L; Miao W; Zhang H; Zeng F; Cao C; Qiu R; Yang J; Luo F; Yan J; Lv H; Xu Q
    J Biomed Nanotechnol; 2014 Nov; 10(11):3373-80. PubMed ID: 26000395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathway.
    Zeng F; Luo F; Lv S; Zhang H; Cao C; Chen X; Wang S; Li Z; Wang X; Dou X; Dai Y; He M; Zhang Y; Lv H; Yan J; Chen Y
    Anticancer Drugs; 2014 Jul; 25(6):663-72. PubMed ID: 24583771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effect of neuropilin-1 monoclonal antibody (NRP-1 MAb) on glioma tumor in mice.
    Chen L; Miao W; Tang X; Zhang H; Wang S; Luo F; Yan J
    J Biomed Nanotechnol; 2013 Apr; 9(4):551-8. PubMed ID: 23621013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression and significance of neuropilin-1 (NRP-1) on glioma cell lines and glioma tissues.
    Chen L; Miao W; Tang X; Zhang H; Wang S; Luo F; Yan J
    J Biomed Nanotechnol; 2013 Apr; 9(4):559-63. PubMed ID: 23621014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of dominant-negative form of Ets-1 suppresses fibronectin-stimulated cell adhesion and migration through down-regulation of integrin alpha5 expression in U251 glioma cell line.
    Kita D; Takino T; Nakada M; Takahashi T; Yamashita J; Sato H
    Cancer Res; 2001 Nov; 61(21):7985-91. PubMed ID: 11691823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPECT imaging of neuropilin receptor type-1 expression with 131I-labeled monoclonal antibody.
    Dou X; Yan J; Zhang Y; Liu P; Jiang Y; Lv S; Zeng F; Chen X; Wang S; Zhang H; Wu H; Zhang H; Ouyang L; Su X
    Int J Oncol; 2016 Sep; 49(3):961-70. PubMed ID: 27315007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of beta1-integrin, fibronectin and laminin on invasive behavior of human gliomas].
    Huang JM; Tian XX; Zhong YF; Ma DL; Ma Y; You JF; Zhang Y
    Zhonghua Bing Li Xue Za Zhi; 2006 Aug; 35(8):478-82. PubMed ID: 17069701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel monoclonal antibody, L1A3, is directed to the functional site of the alpha v integrin subunit.
    Deryugina EI; Strongin A; Yu C; Bourdon MA
    Hybridoma; 1996 Aug; 15(4):279-88. PubMed ID: 8880215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropilin-1 (NRP-1)/GIPC1 pathway mediates glioma progression.
    Zhang G; Chen L; Sun K; Khan AA; Yan J; Liu H; Lu A; Gu N
    Tumour Biol; 2016 Oct; 37(10):13777-13788. PubMed ID: 27481513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of ROS-alpha v beta 3 integrin-FAK/Pyk2 in the inhibitory effect of melatonin on U251 glioma cell migration and invasion under hypoxia.
    Xu CS; Wang ZF; Huang XD; Dai LM; Cao CJ; Li ZQ
    J Transl Med; 2015 Mar; 13():95. PubMed ID: 25889845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neuropilin-1 monoclonal antibody suppresses the migration and invasion of human gastric cancer cells via Akt dephosphorylation.
    Ding Y; Zhou J; Wang S; Li Y; Mi Y; Gao S; Xu Y; Chen Y; Yan J
    Exp Ther Med; 2018 Aug; 16(2):537-546. PubMed ID: 30116312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels.
    Xu P; Zou M; Wang S; Wang L; Wang L; Luo F; Wu T; Yan J
    Anticancer Drugs; 2019 Jun; 30(5):441-450. PubMed ID: 30807552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-1 (NRP-1) and Magnetic Nanoparticles, a Potential Combination for Diagnosis and Therapy of Gliomas.
    Chen L; Zhang G; Shi Y; Qiu R; Khan AA
    Curr Pharm Des; 2015; 21(37):5434-49. PubMed ID: 26377659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody against NRP-1 b1b2.
    Li X; Luo F; Wang S; Ni E; Tang X; Lv H; Chen X; Chen L; Yan J
    Hybridoma (Larchmt); 2011 Aug; 30(4):369-73. PubMed ID: 21851237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of neuropilin-1 on macrophages modulates antibody-mediated tumoricidal activity.
    Kawaguchi K; Suzuki E; Nishie M; Kii I; Kataoka TR; Hirata M; Inoue M; Pu F; Iwaisako K; Tsuda M; Yamaguchi A; Haga H; Hagiwara M; Toi M
    Cancer Immunol Immunother; 2017 Sep; 66(9):1131-1142. PubMed ID: 28432397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Saturated Neuropilin-1 Expression in Normal Tissue Maximizes Tumor Exposure to Anti-Neuropilin-1 Monoclonal Antibody.
    Ma C; Dou X; Yan J; Wang S; Yang R; Su F; Zhang H; Su X
    Anticancer Agents Med Chem; 2019; 19(18):2269-2275. PubMed ID: 31692439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropilin-1 stimulates tumor growth by increasing fibronectin fibril assembly in the tumor microenvironment.
    Yaqoob U; Cao S; Shergill U; Jagavelu K; Geng Z; Yin M; de Assuncao TM; Cao Y; Szabolcs A; Thorgeirsson S; Schwartz M; Yang JD; Ehman R; Roberts L; Mukhopadhyay D; Shah VH
    Cancer Res; 2012 Aug; 72(16):4047-59. PubMed ID: 22738912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA interference targeting NRP-1 inhibits human glioma cell proliferation and enhances cell apoptosis.
    Li X; Tang T; Lu X; Zhou H; Huang Y
    Mol Med Rep; 2011; 4(6):1261-6. PubMed ID: 21842123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GPNMB cooperates with neuropilin-1 to promote mammary tumor growth and engages integrin α5β1 for efficient breast cancer metastasis.
    Maric G; Annis MG; Dong Z; Rose AA; Ng S; Perkins D; MacDonald PA; Ouellet V; Russo C; Siegel PM
    Oncogene; 2015 Oct; 34(43):5494-504. PubMed ID: 25772243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenascin-C promotes microvascular cell migration and phosphorylation of focal adhesion kinase.
    Zagzag D; Shiff B; Jallo GI; Greco MA; Blanco C; Cohen H; Hukin J; Allen JC; Friedlander DR
    Cancer Res; 2002 May; 62(9):2660-8. PubMed ID: 11980665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.